DD210909A5 - Verfahren zur herstellung von substituierten 3,4-diamino-1,2,5-thiadiazolverbindungen - Google Patents

Verfahren zur herstellung von substituierten 3,4-diamino-1,2,5-thiadiazolverbindungen Download PDF

Info

Publication number
DD210909A5
DD210909A5 DD83249300A DD24930083A DD210909A5 DD 210909 A5 DD210909 A5 DD 210909A5 DD 83249300 A DD83249300 A DD 83249300A DD 24930083 A DD24930083 A DD 24930083A DD 210909 A5 DD210909 A5 DD 210909A5
Authority
DD
German Democratic Republic
Prior art keywords
thiadiazole
amino
general formula
compound
alkyl
Prior art date
Application number
DD83249300A
Other languages
German (de)
English (en)
Inventor
Ronnie R Crenshaw
Aldo A Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DD210909A5 publication Critical patent/DD210909A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
DD83249300A 1982-03-29 1983-03-29 Verfahren zur herstellung von substituierten 3,4-diamino-1,2,5-thiadiazolverbindungen DD210909A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (1)

Publication Number Publication Date
DD210909A5 true DD210909A5 (de) 1984-06-27

Family

ID=23429274

Family Applications (2)

Application Number Title Priority Date Filing Date
DD83249300A DD210909A5 (de) 1982-03-29 1983-03-29 Verfahren zur herstellung von substituierten 3,4-diamino-1,2,5-thiadiazolverbindungen
DD83260707A DD219768A5 (de) 1982-03-29 1983-03-29 Verfahren zur herstellung von substituierten aethandiimidamid-zwischenprodukten, die zur herstellung von substitituierten 3,4-diamino-1,2,5-thiadiazolverbindungen dienen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD83260707A DD219768A5 (de) 1982-03-29 1983-03-29 Verfahren zur herstellung von substituierten aethandiimidamid-zwischenprodukten, die zur herstellung von substitituierten 3,4-diamino-1,2,5-thiadiazolverbindungen dienen

Country Status (30)

Country Link
JP (2) JPS58180477A (OSRAM)
KR (1) KR880002209B1 (OSRAM)
AT (1) AT386599B (OSRAM)
AU (2) AU557577B2 (OSRAM)
BE (1) BE896291A (OSRAM)
CH (2) CH660880A5 (OSRAM)
CS (2) CS250240B2 (OSRAM)
DD (2) DD210909A5 (OSRAM)
DE (1) DE3311281A1 (OSRAM)
DK (2) DK166677B1 (OSRAM)
ES (3) ES520982A0 (OSRAM)
FR (2) FR2542741B1 (OSRAM)
GB (2) GB2117769B (OSRAM)
GR (1) GR78524B (OSRAM)
HU (2) HU188742B (OSRAM)
IE (1) IE55596B1 (OSRAM)
IL (1) IL68259A0 (OSRAM)
IT (1) IT1164633B (OSRAM)
LU (1) LU84716A1 (OSRAM)
MY (1) MY8700942A (OSRAM)
NL (1) NL8301063A (OSRAM)
NO (1) NO163055C (OSRAM)
NZ (1) NZ203726A (OSRAM)
OA (1) OA07356A (OSRAM)
PT (1) PT76459B (OSRAM)
SE (2) SE461040B (OSRAM)
SU (2) SU1419518A3 (OSRAM)
YU (1) YU44849B (OSRAM)
ZA (1) ZA832154B (OSRAM)
ZW (1) ZW7683A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
NL189197C (nl) * 1979-09-04 1993-02-01 Bristol Myers Squibb Co 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten.
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
IE830686L (en) 1983-09-29
SE8704689L (sv) 1987-11-25
SE464302B (sv) 1991-04-08
GB2149406A (en) 1985-06-12
SU1355123A3 (ru) 1987-11-23
ZA832154B (en) 1983-12-28
ES8505978A1 (es) 1985-06-16
JPS58180477A (ja) 1983-10-21
IE55596B1 (en) 1990-11-21
GR78524B (OSRAM) 1984-09-27
DK141383A (da) 1983-09-30
SE461040B (sv) 1989-12-18
AU6327286A (en) 1987-01-08
PT76459A (en) 1983-04-01
YU44849B (en) 1991-04-30
AU586037B2 (en) 1989-06-29
IT1164633B (it) 1987-04-15
LU84716A1 (fr) 1983-12-05
DD219768A5 (de) 1985-03-13
KR840004095A (ko) 1984-10-06
AT386599B (de) 1988-09-12
CH660880A5 (de) 1987-05-29
FR2597867B1 (fr) 1989-12-08
ES8404683A1 (es) 1984-05-16
GB2117769B (en) 1985-08-29
SE8301725L (sv) 1983-11-25
DK81192A (da) 1992-06-18
PT76459B (en) 1986-03-11
HU188742B (en) 1986-05-28
ES520982A0 (es) 1984-05-16
GB8308518D0 (en) 1983-05-05
DK141383D0 (da) 1983-03-28
FR2542741A1 (fr) 1984-09-21
CS250229B2 (en) 1987-04-16
AU1290783A (en) 1983-10-06
NO831100L (no) 1983-09-30
ES527686A0 (es) 1985-06-16
OA07356A (fr) 1984-08-31
ATA111083A (de) 1988-02-15
GB8432809D0 (en) 1985-02-06
DK166677B1 (da) 1993-06-28
JPH0568472B2 (OSRAM) 1993-09-29
NZ203726A (en) 1986-05-09
SE8301725D0 (sv) 1983-03-28
KR880002209B1 (ko) 1988-10-18
FR2542741B1 (fr) 1989-12-08
IL68259A0 (en) 1983-06-15
YU74483A (en) 1986-02-28
SE8704689D0 (sv) 1987-11-25
GB2117769A (en) 1983-10-19
NL8301063A (nl) 1983-10-17
IT8348005A0 (it) 1983-03-28
DK81192D0 (da) 1992-06-18
SU1419518A3 (ru) 1988-08-23
JPH06135925A (ja) 1994-05-17
BE896291A (fr) 1983-09-28
GB2149406B (en) 1986-01-02
ZW7683A1 (en) 1984-01-04
NO163055B (no) 1989-12-18
FR2597867A1 (fr) 1987-10-30
ES527685A0 (es) 1985-06-16
AU557577B2 (en) 1986-12-24
ES8505977A1 (es) 1985-06-16
NO163055C (no) 1990-03-28
MY8700942A (en) 1987-12-31
DE3311281A1 (de) 1983-11-24
CH655111A5 (de) 1986-03-27
CS250240B2 (en) 1987-04-16
HU196386B (en) 1988-11-28

Similar Documents

Publication Publication Date Title
DE3218584C2 (OSRAM)
DD141520A5 (de) Verfahren zur herstellung neuer derivate von 4-amino-5-alkylsulfonyl-ortho-anisamiden
EP0001279A1 (de) Imidazolderivate deren Herstellung und diese enthaltende Präparate
DE69023928T2 (de) DIAMINVERBINDUNGEN UND ARZNEIMITTEL GEGEN CEREBRALE STöRUNGEN DIE DIESE ENTHALTEN.
DE2322880C2 (de) 4-(Imidazolin-2-ylamino)-2,1,3-benzothiadiazole und Verfahren zu deren Herstellung
DD200371A5 (de) Verfahren zur herstellung von 2,4-disubstituierten thiazolen
EP0153277A2 (de) Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
CH641772A5 (de) Cyanoguanidin-derivate und verfahren zu ihrer herstellung.
DD216929A5 (de) Verfahren zur herstellung von thiazolidinderivaten
DD218364A5 (de) Verfahren zur herstellung von 3-(amino- oder subst.-amino)-4-(subst.-amino)-1,2,5-thiadiazol verbindungen
DE2847792C2 (OSRAM)
DE2938990C2 (OSRAM)
DE2720545A1 (de) Neue chinazolinderivate, ihre herstellung und pharmazeutische mittel
DE1913199B2 (de) Mannichbasen aus alpha-Tetralon bzw. dessen Derivaten und Arylalkylaminen und deren Salze
DD210909A5 (de) Verfahren zur herstellung von substituierten 3,4-diamino-1,2,5-thiadiazolverbindungen
DE68917333T2 (de) Heterocyclische Verbindungen und Antiulkusmittel.
DE3014813A1 (de) 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate
EP0211157B1 (de) Isoxazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutischen Präparate
EP0139627B1 (de) Verfahren zur Herstellung von neuen in 5-Stellung substituierten 5,10-Dihydro-11H-dibenzo(b,e)(1,4)diazepin-11-onen
DE2063996A1 (de) Neue Tuberkulostatisch wirkende alpha Aminoxy hydroxamsaurederivate und Verfahren zur Herstellung derselben
DD253616A5 (de) Verfahren zur herstellung von neuen pleunromutilinderivaten
DE2824066A1 (de) Neue, zur ulcusbehandlung brauchbare verbindungen, verfahren zu deren herstellung, arzneimittel und zwischenprodukte
DE2605824C3 (de) N-Acylaniline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2513136B2 (de) N-(I -Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
AT387384B (de) Verfahren zur herstellung von thiadiazolderivaten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee